SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

LUPINI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.517
AS - Asia 2.367
EU - Europa 1.914
SA - Sud America 315
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 58
OC - Oceania 3
Totale 10.283
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.311
SG - Singapore 877
CN - Cina 573
IT - Italia 502
DE - Germania 294
VN - Vietnam 281
PL - Polonia 273
BR - Brasile 234
FI - Finlandia 189
HK - Hong Kong 175
GB - Regno Unito 170
TR - Turchia 133
UA - Ucraina 104
CA - Canada 95
SE - Svezia 68
FR - Francia 63
RU - Federazione Russa 61
BD - Bangladesh 58
IN - India 53
JP - Giappone 49
ID - Indonesia 45
MX - Messico 44
NL - Olanda 33
BE - Belgio 31
AR - Argentina 27
RO - Romania 21
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
IQ - Iraq 18
AT - Austria 16
ES - Italia 16
LT - Lituania 14
CO - Colombia 13
CR - Costa Rica 13
PK - Pakistan 13
IE - Irlanda 11
MY - Malesia 10
CL - Cile 9
EC - Ecuador 9
JM - Giamaica 9
NI - Nicaragua 9
TN - Tunisia 9
VE - Venezuela 9
EG - Egitto 8
GT - Guatemala 7
IL - Israele 7
IR - Iran 7
PH - Filippine 7
SA - Arabia Saudita 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
PE - Perù 6
BO - Bolivia 5
DZ - Algeria 5
KE - Kenya 5
KZ - Kazakistan 5
OM - Oman 5
SC - Seychelles 5
SV - El Salvador 5
AL - Albania 4
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
JO - Giordania 4
NP - Nepal 4
AU - Australia 3
GP - Guadalupe 3
GR - Grecia 3
HN - Honduras 3
LV - Lettonia 3
MA - Marocco 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
PY - Paraguay 2
QA - Qatar 2
AD - Andorra 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
EU - Europa 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KY - Cayman, isole 1
LU - Lussemburgo 1
Totale 10.168
Salva come PNG Salva come JPEG
Città #
Ashburn 712
Singapore 523
Fairfield 430
San Jose 373
Woodbridge 350
Warsaw 271
Houston 230
Ann Arbor 223
Beijing 216
Chandler 203
Santa Clara 191
Seattle 178
Hong Kong 174
Munich 171
Council Bluffs 168
Cambridge 135
Wilmington 129
Jacksonville 126
New York 118
Ferrara 114
Dallas 113
Helsinki 113
Ho Chi Minh City 95
Los Angeles 82
Milan 68
Izmir 66
Hanoi 53
Tokyo 49
Turku 47
Shanghai 46
Nanjing 45
Princeton 38
Jakarta 36
Orem 36
Phoenix 35
Lauterbourg 34
Rome 32
Brussels 31
Buffalo 29
Chicago 29
London 29
Boardman 27
Mexico City 27
Montreal 27
San Diego 27
Atlanta 25
São Paulo 24
Tianjin 23
Toronto 22
Denver 21
Nanchang 21
The Dalles 21
Bologna 20
Bremen 19
Brooklyn 19
Addison 17
Da Nang 17
Timisoara 17
Falls Church 16
Amsterdam 14
Chennai 14
Johannesburg 14
Washington 14
Brno 13
Dong Ket 13
Shenyang 13
Changsha 12
Haiphong 12
Manchester 12
Naples 12
Nuremberg 12
San Francisco 12
San José 12
Boston 11
Stockholm 11
Charlotte 10
Dublin 10
Poplar 10
Redwood City 10
Rio de Janeiro 10
Dearborn 9
Hebei 9
Moscow 9
Barnet 8
Columbus 8
Frankfurt am Main 8
Kunming 8
Managua 8
Philadelphia 8
Santiago 7
Ankara 6
Auburn Hills 6
Baghdad 6
Belo Horizonte 6
Falkenstein 6
Hangzhou 6
Hefei 6
Jiaxing 6
Mountain View 6
Palermo 6
Totale 6.924
Salva come PNG Salva come JPEG
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 362
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 344
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 336
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 329
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 323
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 321
Ruolo del miR-221 nella tumorigenesi epatica 307
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 304
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 297
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 292
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 283
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 279
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 275
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 270
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 269
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 265
Circulating non-coding RNA as biomarkers in colorectal cancer 254
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 250
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 250
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 248
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 245
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 243
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 236
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 235
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 228
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 226
Mutated beta-catenin evades a microRNA-dependent regulatory loop 221
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 217
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 207
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 206
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 199
Oncogenic role of miR-483-3p at the IGF2/483 locus 194
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 191
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 188
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 186
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 179
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 177
The importance of microRNAs in RAS oncogenic activation in human cancer 174
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 163
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 144
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 137
null 89
null 77
null 63
Totale 10.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.872
Totale 45.977
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022368 0 0 0 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20263.580 389 135 267 394 502 242 488 220 386 323 168 66
2026/20271.018 89 166 363 400 0 0 0 0 0 0 0 0
Totale 10.283